These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. [Current state of treatment of rheumatoid arthritis and systemic lupus erythematosus with cytotoxic drugs]. Dekker DL; Steĭnberg AD Ter Arkh; 1976; 48(11):79-88. PubMed ID: 1021897 [No Abstract] [Full Text] [Related]
48. Treatment of articular and non-articular (rheumatic diseases by indomethacin suppositories). Vaishnava H; Dasgupta MK; Sachar MS J Assoc Physicians India; 1971 Feb; 19(2):157-65. PubMed ID: 4934419 [No Abstract] [Full Text] [Related]
49. [Treatment of collagen diseases--a questionnaire survey in Japan (author's transl)]. Nobunaga M; Shiokawa Y Ryumachi; 1980 Jun; 20(3):140-50. PubMed ID: 7414429 [No Abstract] [Full Text] [Related]
50. [Double disease in rheumatology]. González T; Gantes M Med Clin (Barc); 1986 Jan; 86(1):15-7. PubMed ID: 3959623 [No Abstract] [Full Text] [Related]
51. [Long-term, small-dose cyclophosphamide treatment of severe inflammatory joint diseases]. Chaouat Y; Paquet J; Pélisson J; Kanovitch B; Rascovscki S Rev Rhum Mal Osteoartic; 1968 Dec; 35(12):649-56. PubMed ID: 5717215 [No Abstract] [Full Text] [Related]
52. Repeated cyclosporine therapy of peripheral arthritis associated with ankylosing spondylitis. Géher P; Gömör B Med Sci Monit; 2001; 7(1):105-7. PubMed ID: 11208503 [TBL] [Abstract][Full Text] [Related]
53. [On the critical evaluation of immunosuppressive therapy in progressive chronic polyarthritis]. Otto W Z Gesamte Inn Med; 1969 May; 24(10):147-8. PubMed ID: 5807424 [No Abstract] [Full Text] [Related]
54. [Infections and immunosuppressive agents in rheumatology]. Kahn MF; Vitale C; Grimaldi A Sem Hop; 1976 Jun 9-16; 52(22-23):1374-6. PubMed ID: 183273 [TBL] [Abstract][Full Text] [Related]
55. [Therapeutic use of chloroquine. (Review)]. De Carlo M; Russo V Arch Ital Sci Med Trop Parassitol; 1970; 51(7):97-121. PubMed ID: 4402155 [No Abstract] [Full Text] [Related]
56. [Critical evaluation of the immunosuppressive therapy of chronic progressive polyarthritis]. Otto W Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:147-8. PubMed ID: 5402571 [No Abstract] [Full Text] [Related]
57. [Treatment of rheumatic diseases with cytostatic drugs]. Fredriksen W; Dale I Tidsskr Nor Laegeforen; 1969 Nov; 89(21):1646-9. PubMed ID: 5398051 [No Abstract] [Full Text] [Related]
58. Considerations on the intraarticular treatment of rheumatoid polyarthritis with cytostatics of the clafen and endoxan type. Stoia I; Marin D; Vainer C; Gorun A; Irimescu C; Nitescu S; Poetas M; Athanasiu P; Petrescu A; Copelovici Y Rom Med Rev; 1970; 14(1):32-4. PubMed ID: 5439219 [No Abstract] [Full Text] [Related]
59. Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab. Conti F; Priori R; Chimenti MS; Coari G; Annovazzi A; Valesini G; Signore A Arthritis Rheum; 2005 Apr; 52(4):1224-6. PubMed ID: 15818709 [TBL] [Abstract][Full Text] [Related]
60. Mechanism of actions of immunosuppressive drugs. Barnett EV Proc Clin Dial Transplant Forum; 1974; (4):80-2. PubMed ID: 4468426 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]